Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Kissei

Status and phase: Withdrawn; Phase 3

Conditions: Overactive Bladder

Treatments: Drug: KUC-7483

Study type: Interventional

Funder types: Industry

Identifiers

NCT01003405

KUC1302

Details and patient eligibility

About

To investigate the long-term safety, efficacy and pharmacokinetics of KUC-7483 in patients with overactive bladder.

Enrollment: 100 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients who have successfully completed the Phase III double-blind study.

Exclusion criteria

• Patients with serious adverse events or clinically significant adverse events in the Phase III double-blind study.

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

KUC-7483

Experimental group

Treatment:

Drug: KUC-7483